GE HealthCare Technologies PDx — Segment Reporting, Other Segment Item, Amount increased by 6.4% to $167.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 25.6%, from $133.00M to $167.00M. Over 3 years (FY 2022 to FY 2025), PDx — Segment Reporting, Other Segment Item, Amount shows an upward trend with a 10.2% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
An increase may signal rising administrative overhead or non-recurring charges, while a decrease suggests improved cost allocation or reduced segment-specific overhead.
Captures miscellaneous operating expenses or adjustments specifically allocated to the Pharmaceutical Diagnostics segmen...
Similar to 'unallocated corporate overhead' or 'other operating expenses' found in segment reporting for large-cap healthcare firms.
gehc_segment_pdx_segment_reporting_other_segment_item_amount| Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $108.25M | $108.25M | $108.25M | $108.25M | $124.25M | $124.25M | $124.25M | $124.25M | $126.00M | $125.00M | $120.00M | $119.00M | $133.00M | $144.00M | $145.00M | $157.00M | $167.00M |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | +14.8% | +0.0% | +0.0% | +0.0% | +1.4% | -0.8% | -4.0% | -0.8% | +11.8% | +8.3% | +0.7% | +8.3% | +6.4% |
| YoY Change | — | — | — | — | +14.8% | +14.8% | +14.8% | +14.8% | +1.4% | +0.6% | -3.4% | -4.2% | +5.6% | +15.2% | +20.8% | +31.9% | +25.6% |